NCT04848935
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting
Not Applicable
Drug Category: Other

Key Eligibility Criteria:

Gender: All
Age: 21 Years to 99 Years (Adult, Older Adult)
Location of Metastases: Brain
Additional Notes: Patients must have brain metastasis that require radiation therapy
Exclusions: Patients with prior stereotactic radiosurgery
https://ClinicalTrials.gov/show/NCT04848935